Clinical Trials · NCT05702905
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Peking University First Hospital
- Enrollment
- 75
- Start date
- May 2023
- Locations
- 1 site, China
- Primary endpoint
- Percentage change in bodyweight at 12 weeks for semaglutide versus metformin